Amgen Inc buys back stock (pending)


US - IN March ####, Amgen Inc, a biotechnology company, authorized the reupurchase, of up to $#.### mil of the company's common stock outstanding in open market transactions.

Deal Information

Credit & Investment Research

Market Research

News